Metabolon and the Scottish Early Rheumatoid Arthritis (SERA) Study Announce Partnership to Leverage Metabolomics Data to Better Understand the Molecular Mechanisms of Rheumatoid Arthritis
- Written by PR Newswire
 |
Partnership seeks to identify rheumatoid arthritis biomarkers to improve understanding of disease risk, progression, and treatment responses
MORRISVILLE, N.C. and GLASGOW, Scotland, Aug. 28, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic,...
